Epithelioid hemangioma (EH) is a unique benign vasoformative tumor composed of epithelioid endothelial cells. Although a small subset of EHs with atypical features harbor ZFP36-FOSB fusions, no additional genetic abnormalities have been found to date in the remaining cases. On the basis of a novel FOS-LMNA gene fusion identified by RNA sequencing in an index case of a skeletal EH with typical morphology, we sought to investigate the prevalence of FOS rearrangement in a large cohort of EHs. Thus 57 additional EH cases lacking FOSB rearrangements were studied for FOS gene abnormalities by fluorescence in situ hybridization, and results were correlated with morphologic appearance and clinical presentation. The EHs were subclassified as typical (n = 25), cellular (n = 21), and angiolymphoid hyperplasia with eosinophilia (ALHE) (n = 12) variants. The ALHE was defined as an EH with a vascular "blow-out" pattern associated with a variable degree of inflammation. There were 17 (29%) cases bearing FOS gene rearrangements among 58 cases tested, including 12 male and 5 female patients, with a mean age of 42 years. Most FOS-rearranged EHs occurred in the bone (10) and soft tissue (6), whereas only 1 case was cutaneous. The predominant anatomic site was the extremity (12), followed by trunk (3), head and neck (1), and penis (1). The incidence of FOS rearrangement was significantly higher in bone (59%, P = 0.006) and lower in head and neck (5%, P = 0.009). Twelve of the FOS-rearranged cases were cellular EH (P = 0.001) associated with moderate mitotic activity (2 to 5/10 HPF) and milder inflammatory background. All 12 ALHE cases lacked FOS gene abnormalities, suggesting different pathogenesis. In conclusion, FOS rearrangement was present in a third of EHs across different locations and histologic variants; however, it was more prevalent in cellular EH and intraosseous lesions, compared with those in skin, soft tissue, and head and neck. This genetic abnormality can be useful in challenging cases, to distinguish cellular EHs from malignant epithelioid vascular tumors. These results also suggest that dysregulation of the FOS family of transcription factors through chromosomal translocation is as a key event in the tumorigenesis of EH except for the ALHE variant.
E pithelioid hemangioma (EH) is an uncommon but distinctive vascular neoplasm displaying well-formed vascular channels lined by prominent epithelioid endothelial cells. [1] [2] [3] As suggested from the variety of its previous designations, such as intravenous atypical vascular proliferation, 4 angiolymphoid hyperplasia with eosinophilia (ALHE), 5, 6 inflammatory angiomatous nodule, 7 and histiocytoid hemangioma, 8 the morphologic spectrum of EH exhibits a wide range of appearances, including intravascular growth, a heavy inflammatory infiltrate, and a cellular/solid proliferation. Although initially described as having predilection for the skin and subcutis of the head and neck, further studies documented its ubiquitous anatomic location, involving deep soft tissue, bone, lymph nodes, lung, eye, colon, heart, spleen, and penis. 9 Because of its diverse histomorphologies, the diagnosis of EH remains challenging, being confused at one end of the spectrum (ALHE) with other inflammatory conditions (eg, Kimura disease), whereas at the other end of the spectrum (cellular EH) with malignant epithelioid vascular tumors, such as epithelioid hemangioendothelioma (EHE) and epithelioid angiosarcoma (AS). Moreover, the distinction from malignant lesions is further complicated by the aggressive clinical presentation of intraosseous EH with destructive growth and/or multifocality or by the presence of atypical histologic features with increased mitotic activity and necrosis. 2, 3, 10 Although our group has recently identified recurrent ZFP36-FOSB fusions in a small subset of EH with atypical features, 10 the underlying genetic alteration responsible for most EHs remains elusive. In this study, we took advantage of an index case with available frozen tissue, which was subjected to RNA sequencing and FusionSeq analysis, to identify novel gene rearrangements. The gene fusion candidate was then validated and screened in a large set of EHs of various morphologic appearances and clinical presentations to determine its frequency and to evaluate genotype-phenotype correlations.
MATERIALS AND METHODS

Patient Cohort and Pathologic Classification
The study cohort of 58 EHs was collected from the archives of MSKCC Surgical Pathology files, the personal consultations of the senior authors (C.R.A., C.D.M.F.) and Dr Hsuan-Ying Huang (see the Acknowledgement section). All cases selected lacked FOSB gene abnormalities by fluorescence in situ hybridization (FISH). The diagnostic criteria for EH included predominant epithelioid morphology of the endothelial cells, with moderate to abundant eosinophilic cytoplasm, and at least focal areas of overt vasoformative features. There was no frank endothelial multilayering nor significant cytologic atypia. The endothelial differentiation of epithelioid tumor cells was confirmed by CD34, CD31, and/or ERG immunohistochemistry in all cases. The EHs were further subclassified as typical, cellular, and ALHE variants. The cellular EHs were defined as having a solid growth in >50% of the tumor. EH characterized by distinct involvement of vessel wall with centrifugal growth and variable inflammatory infiltrate was categorized as an ALHE variant. 6 The study was approved by the Institutional Review Board 02-060.
RNA Sequencing
Total RNA was extracted from the frozen tissue available in the index case by Trizol reagent (Invitrogen, Carlsbad, CA) and prepared for RNA sequencing in accordance with the standard Illumina mRNA sample preparation protocol (Illumina, San Diego, CA). Briefly, mRNA was isolated with oligo(dT) magnetic beads from total RNA (10 mg). The mRNA was fragmented by incubation at 941C for 2.5 minutes in fragmentation buffer (Illumina). To reduce the inclusion of artifactual chimeric transcripts due to random priming of transcript fragments into the sequencing library because of inefficient Atailing reactions that lead to self-ligation of blunt-ended template molecules, 11 an additional gel size-selection step (capturing 350 to 400 bp) was introduced before the adapter ligation step. The adaptor-ligated library was then enriched by polymerase chain reaction (PCR) for 15 cycles and purified. The library was sized and quantified using DNA1000 Kit (Agilent, Santa Clara, CA) on an Agilent 2100 Bioanalyzer according to the manufacturer's instructions. Paired-end RNA sequencing at read lengths of 50 or 51 bp was performed with the HiSeq 2500 (Illumina). A total of about 38 million paired-end reads were generated, corresponding to about 3.8 billion bases.
Analysis of RNA Sequencing Results With FusionSeq Method
All reads were independently aligned with the STAR alignment software against the human genome sequence (hg19) and a splice junction library, simultaneously. 12 The mapped reads were converted into Mapped Read Format 13 and analyzed with FusionSeq 14 to identify potential fusion transcripts. Briefly, paired-end reads mapped to different genes are first used to identify potential chimeric candidates. A cascade of filters, each taking into account different sources of noise in RNA sequencing experiments, was then applied to remove spurious fusion transcript candidates. Once a confident list of fusion candidates was generated, they were ranked with several statistics to prioritize the experimental validation. In these cases, we used the DASPER score (difference between the observed and analytically calculated expected SPER): a higher DASPER score indicated a greater likelihood that the fusion candidate was authentic and did not occur randomly.
Fluorescence In Situ Hybridization
FISH on interphase nuclei from paraffin-embedded 4-mm-thick sections was performed applying custom probes using bacterial artificial chromosomes (BAC), covering and flanking genes that were identified as potential fusion partners in the RNA-seq experiment. BAC clones were chosen according to the UCSC genome browser (http://genome.ucsc.edu) (Supplementary Table 1 , Supplemental Digital Content 1, http://links.lww.com/ PAS/A290). The BAC clones were obtained from BACPAC sources of Children's Hospital of Oakland Research Institute (Oakland, CA) (http://bacpac.chori. org). DNA from individual BACs was isolated according to the manufacturer's instructions, labeled with different fluorochromes in a nick translation reaction, denatured, and hybridized to pretreated slides. Slides were then incubated, washed, and mounted with DAPI in an antifade solution, as previously described. 15 The genomic location of each BAC set was verified by hybridizing them to normal metaphase chromosomes. Two hundred successive nuclei were examined using a Zeiss fluorescence microscope (Zeiss Axioplan, Oberkochen, Germany), controlled by Isis 5 software (Metasystems, Newton, MA). A positive score was interpreted when at least 20% of the nuclei showed a break-apart signal. Nuclei with incomplete set of signals were omitted from the score.
Reverse Transcription PCR
An aliquot of the RNA extracted above from frozen tissue of the index case by Trizol Reagent (Invitrogen) was used to confirm the novel fusion transcript identified by FusionSeq. RNA quality was determined by Eukaryote Total RNA Nano Assay, and cDNA quality was tested for PGK housekeeping gene (247 bp amplified product). One microgram of total RNA was used for cDNA synthesis by SuperScript III First-Strand Synthesis Kit (Invitrogen). Reverse transcription PCR (RT-PCR) was performed using the Clontech Advantage 2 PCR Enzyme System Kit (Clontech, Mountain View, CA) for 33 cycles at a 651C annealing temperature, using the following primers: FOS exon 3 forward primer, 5 0 -GAGCTGACTGATACAC TCCAAGCG-3 0 , with LMNA intron 3 reverse primer, 5 0 -GACTTGTAATGCCCTCCGAGACC-3 0 , and LMNA intron 3 forward primer, 5 0 -CCATCAGACAAGTTAG GTCATAGGG-3 0 , with FOS exon 4 reverse primer, 5 0 -GA TGCTCTTGACAGGTTCCACTG-3 0 . Amplified products were purified and sequenced by the Sanger method after confirmed by gel electrophoresis.
Statistical Analysis
Statistical analysis was conducted using SPSS software (version 20; IBM, New York, NY). Associations between clinicopathologic characteristics, histologic variants, and FOS rearrangement were evaluated using independent t, Pearson w 2 , or Fisher exact tests according to the variable. Two-sided P values were calculated, and P < 0.05 was considered significant in all statistical analyses.
RESULTS
Clinicopathologic Findings and Histologic Classification of EHs
The study cohort consisted of 35 male and 23 female patients, with the mean age at diagnosis being 42 years (range, 14 to 81 y). The sites of involvement included the extremity (28, 48%), followed by head and neck (20, 34%), trunk (8, 13%), and penis (2, 3%). Within the extremities, there were 17 cases in the upper limb, including 5 cases involving the hands, and 11 cases in the lower limb, with 9 cases involving the feet. Overall, the study included 10 cutaneous (17%), 31 soft tissue (54%), and 17 intraosseous (29%) cases. Seven of the 10 cutaneous EHs occurred in a head and neck location, while two arose in the upper limb and one in the penis. Among 35 cases with available data, there were 7 patients presenting with multifocal lesions, 3 of them occurring in the bone.
The majority of cases were circumscribed and unencapsulated within a hemorrhagic background and hemosiderin-laden histiocytes. Most tumors had a distinctive lobulated growth, whereas 3 cases demonstrated a more infiltrative pattern with ill-defined borders. Two cases were entirely confined within a large-caliber muscular vascular lumen, indicating an intravascular location. The 58 cases were further divided into typical (25 cases, 43%), cellular (21, 36%), and ALHE (12, 21%). Increased mi-totic activity (> 1/10 HPF) occurred mostly in the cellular variant, but nuclear atypia and necrosis was observed in a subset of all variants. Marked inflammation with a prominent eosinophilic infiltrate was seen across all different histologic subtypes, including 5 typical, 2 cellular, and 9 ALHE variants. Among the 20 head and neck cases, 19 cases occurred in skin or superficial soft tissue and 1 in the mandible. Most head and neck EHs (75%) showed a moderate to marked inflammatory infiltrate. Subsequent FISH analysis, using a break-apart assay, showed rearrangements in both FOS and LMNA genes (Fig. 2D ).
Clinical and Histologic Features of FOS-rearranged EHs
Most of the FOS-rearranged EH occurred in bone (10, 59%) and soft tissue (6), whereas only 1 was cutaneous, being a lesion on the penis. The predominant anatomic site affected was the extremities (12, 71%), with few examples in the trunk (3), head and neck (1), and penis (1). Histologically, 12 cases (70%) had increased cellularity and a solid growth pattern (Figs. 1C-G), corresponding to the cellular variant, whereas 5 were characterized by a typical histology (Fig. 1H ). The only cutaneous FOS-rearranged EH involved the penis and showed an infiltrating pattern (Fig. 1I ), whereas 1 cellular EH displayed intravascular growth (Fig. 1C) . One cellular and 1 typical EH were associated with marked inflammation including eosinophils (Figs. 1G, H) . Only 1 FOS-rearranged EH demonstrated focal necrosis. FOS rearrangements had a higher prevalence among the cellular type (57%, P = 0.001), intraosseous location (59%, P = 0.006), lesions with minimal to mild inflammatory reaction (44%, P = 0.023), and lesions with moderately elevated mitotic activity (2 to 5/10 HPF, 60%, P = 0.004), but was unrelated to the presence of necrosis, percentage of vacuolated cells, or eosinophilic infiltrate. Of the 10 patients with available follow-up data, 2 developed local recurrences at 7 months and 4 years after surgery, whereas the remainder were with no evidence of disease at last follow-up (mean 36.9 mo, range 0.3 to 108 mo).
All 12 cases with features of ALHE were negative for FOS rearrangement, with 6 cases occurring in the head and neck, 5 cases in the extremities, and 1 case in the axilla. All except 1 case had moderate to marked inflammatory infiltrate with heavy eosinophilic component.
None of the remaining 57 cases showed the presence of an LMNA gene rearrangement by FISH. As FOSL1 and FOSL2 are members of the same family of FOS FIGURE 1. Pathologic findings of the FOS-rearranged EH cases. A, The index case (case #1), positive for FOS-LMNA fusion, showed a typical morphology with epithelioid cells surrounding vascular lumina. B, Lesional cells showed glassy eosinophilic cytoplasm with scattered vacuoles, vesicular nuclei, and prominent nucleoli (case #1). C, One of the cellular EH cases (case #14) was confined to a dilated vascular channel, which at higher power (D) was composed of solid sheets of tumor cells. Cellular EH showed (E) variably prominent vascular spaces (case #12), (F) distinctive epithelioid cell features (case #11), and (G) surrounding lymphoid and eosinophilic infiltrates (case #13). H, One typical EH was characterized by a prominent inflammatory background obscuring the proliferating vascular channels (case #15). Eosinophils were usually seen. I, The penile EH (case #4) was composed of typical vasoformative structures but showed a more infiltrating growth pattern. transcription factors, FISH for FOSL1 and FOSL2 gene abnormalities were performed in all EH cases that lacked FOS or FOSB rearrangements. However, none of the 38 EHs tested showed any gene alterations.
Rare FOS-VIM Fusions Are Seen in Intraosseous Cellular EH.
As a previous intraosseous EHE was reported to have a 46, XX, -6, t(10;14)(p13;q24) karyotype, involving the 14q24.3 locus where the FOS gene is located, 16 we hypothesized that it is likely this abnormality was identified in a cellular example of EH rather than an EHE. Thus we designed BAC probes spanning the 10p13 region and found 2 cases of FOS-rearranged EHs showing a break-apart signal in this region (Supplementary Table 1 , Supplemental Digital Content 1, http://links.lww.com/ PAS/A290). Both cases were intraosseous lesions, occurring in the foot of middle aged women (38 and 56 y old, 17 we further confined the break within the VIM gene (Fig. 3D ). Both patients were with no evidence of disease for 2 and 9 years, respectively, after surgery.
DISCUSSION
Although epithelioid vascular tumors ranging from benign EH to malignant EHE and AS share a common epithelioid endothelial morphology, they are distinct pathologic entities with different clinicopathologic features and molecular alterations. Approximately 90% of EHE harbor the recurrent t(1;3)(p36;q25) translocation, resulting in a WWTR1-CAMTA1 fusion, 17 whereas a smaller subset have a t(x;11)(p11;q22) translocation, resulting in a YAP1-TFE3 fusion. 18 AS exhibits instead a more heterogenous genetic profile, including KDR mu-tations limited to the breast location, 19 and/or MYC amplification in most ASs secondary to irradiation or chronic lymphedema, with or without FLT4 coamplification. 20, 21 About 35% of ASs harbor PTPRB or PLCG1 mutations also mostly restricted to radiation-associated AS. 22 In our previous study, 20% of EH harbored ZFP36-FOSB fusions, and one third of them demonstrated moderate nuclear pleomorphism and necrosis. 10 In that study, FOSB rearrangements were seen in two thirds of penile EHs tested, as well as in a small subset of bone and soft tissue lesions. Of interest, the majority of pseudomyogenic hemangioendotheliomas also harbor FOSB rearrangements, showing recurrent fusions with SERPINE1 gene. 23 The terminology of EH has been controversial, with some early reports suggesting that EH of bone represents a variant of EHE with metastasizing potential. 24, 25 However, subsequent studies disproved this notion and indicated that EH of bone, similar to EH of soft tissue or other anatomic locations, is a benign pathologic entity with a low recurrence rate. 2, 3 This concept is now more widely accepted and, as such, is reflected in the current World Health Organization classification for soft tissue and bone tumors. 9 Nevertheless, the diagnosis of EH remains challenging, especially at the cellular/atypical end of the spectrum, wherein correct subclassification is often impeded by the lack of objective molecular markers. In the current study, we sought to further investigate molecular abnormalities in EH, by taking advantage of a case with available frozen tissue for RNA sequencing. The Fu-sionSeq algorithm detected a novel FOS-LMNA gene fusion in the index case of an intraosseous EH with typical morphology. The results were subsequently validated by RT-PCR and FISH. Further recurrent FOS gene rearrangements were then identified in 29% (17/58 cases) of EH cases tested, spanning a variety of anatomic locations and tissue planes (skin, soft tissue, and bone), suggesting a shared genetic abnormality across various clinical presentations. However, the incidence of FOS alterations was unevenly distributed, with EH of the head and neck having a significantly lower incidence (5%, 1/20 cases) compared with that in lesions of extremities (43%, 12/28), trunk (38%, 3/8), and penis (50%, 1/2 cases). Furthermore, the skeletal EHs had the highest incidence of FOS gene rearrangement (59%, 10/17), compared with skin (10%, 1/10) and soft tissue (19%, 6/31). The only FOS-rearranged head and neck EH occurred in the superficial soft tissue; none of the 7 cutaneous lesions of head and neck showed FOS abnormalities by FISH. There was a significant correlation between the presence of FOS gene rearrangements and histologic variant of EH: none of the 12 EH cases displaying centrifugal growth from a muscular vessel had FOS gene abnormalities. This particular histologic appearance is often seen in the head and neck or extremities and was previously classified as ALHE by Fetsch and Weiss, 6 possibly indicating a different pathogenesis.
The FOS gene, known as FBJ murine osteosarcoma viral oncogene homolog and which maps to chromosome 14q24.3, belongs to the Fos gene family including FOSB, FOSL1, and FOSL2. 26, 27 The FOS gene encodes a transcription factor that can dimerize with members of the Jun family (c-Jun, JunB, and JunD), constituting the major components of the activating protein-1 (AP-1) complex. The AP-1 transcription factor binds to TPA-responsive elements (TREs; 5 0 -TGAC/GTCA-3 0 ) of the promoter and enhancer regions of target genes, thereby regulating a wide variety of physiological and tumorigenic processes, including cell proliferation, tumor invasion, distant metastasis, and angiogenesis. 26, 27 c-fos stimulation triggers vascular endothelial growth factor-D (VEGF-D) overexpression, which in turn binds to the vascular and lymphatic receptors VEGFR-2 and VEGFR-3, causing tyrosine phosphorylation and, in human umbilical cord vein endothelial cells (HUVEC), activating proliferation, elongation, and branching to form an extensive network of capillary-like cords in a 3-dimensional matrix. 28 This angiogenic effect initiated by c-FOS-induced VEGF upregulation has been implicated as an important mechanism for cancer pro-gression and failure of peritoneal dialysis. 29, 30 The LMNA gene encodes lamin A and C that are structural protein elements of intranuclear peripheral thin filamentous meshwork, the nuclear lamina. 31, 32 Lamins have been considered key components of the nucleoskeleton in maintaining nuclear structures and involving DNA replication and transcription and heterochromatin organization. LMNA gene rearrangements have been recently described in another mesenchymal tumor, being a 5 0 fusion partner to ALK gene in an inflammatory myofibroblastic tumor. 33 The differential diagnosis of EH includes both EHE and AS. Especially, cellular EH, composed of large solid components, or EH with atypical histologic features, displaying necrosis and moderate cytologic atypia, are particularly challenging to distinguish from malignant epithelioid vascular tumors. Low-power examination may reveal a lobular growth pattern and maturation of the vascular channel formation at the periphery of the lesion with conspicuous concentric layers of pericytes, which would favor a benign EH over other malignant diagnosis. 3 In contrast, EHEs are composed of characteristic strands or cords of epithelioid cells with abundant glassy eosinophilic cytoplasm and prominent cytoplasmic vacuolation, embedded in a distinctive chondromyxoid or hyalinized stroma. Importantly, most EHEs lack well-formed vascular channels, and the only evidence of angiogenic properties is reflected by the so-called blisters cells, in the form of intracytoplasmic lumina. [1] [2] [3] 9, 34 The only notable exception is the TFE3-rearranged EHE, which shares with EH the presence of mature vascular lumen formation, but in contrast displays more significant cytologic atypia and diffuse and strong expression of TFE3. 18 Furthermore, most epithelioid AS show significant cytologic atypia, with hyperchromasia and marked nuclear pleomorphism, which is absent in both cellular and atypical EH. Moreover, in contrast with EH, AS is characterized by infiltrative growth, with irregular anastomosing vascular channels, which are not present in EH. [1] [2] [3] 9, 34 This diagnostic challenge is further illustrated by the couple of reported cases in the cytogenetic literature, documenting 14q24.3 locus abnormalities (corresponding to the FOS gene locus), which are most likely in keeping with a cellular/atypical EH rather than either EHE or AS. 16, 35 On the basis of such a previously reported case with t(10;14)(p13;q24) karyotype, 16 we identified a novel FOS-VIM fusion in 2 intraosseous cellular EH cases by FISH positional cloning. The VIM gene, located at chromosome 10p13, encodes vimentin, a ubiquitous intermediate filament in mesenchymal cells. Along with microtubules and actin microfilaments, vimentin is part of the cytoskeleton, and its overexpression may involve epithelialmesenchymal transformation in cancer progression. 36 This study also sought to address the question whether ALHE, more commonly seen in the head and neck area and extremities, shares similar genetic abnormalities with other EH variants, which are more often seen in bone and soft tissue sites. In the large series by Fetsch and Weiss, 6 approximately half of the 96 EH cases examined were associated with prominent lymphoid follicles and damaged medium-sized vessels. This phenotype is prototypical of ALHE, first described by Wells and Whimster in 1969, 37 occurring predominantly in the subcutaneous tissue of the head and neck region. The key features of ALHE, including a prior history of trauma, lesional maturation over time, even capillary proliferation around a large vessel, the presence of vascular damage, and the extensive degree of inflammation, may suggest a reactive process, distinct from the neoplastic appearance of other EH variants. The distribution of ALHE also coincides with areas susceptible to injury, such as the head and neck and extremities. In the current study, all EH cases displaying a vascular "blowout" pattern, characteristic of ALHE, were devoid of FOS rearrangement, suggesting a different pathogenesis from classic and cellular EH.
In summary, we report novel and recurrent FOS gene rearrangements in nearly one third of EHs across a variety of locations and histologic variants. Of note, FOS abnormalities were present in half of the cellular EH variants and intraosseous lesions. The FOS rearrangements are also much more common in the EH of extremities, trunk, and penis, being seen in 40% to 50% of cases. In contrast, head and neck EHs are rarely affected by this genetic abnormality, and all typical EH cases with centrifugal vascular involvement lack FOS rearrangement, suggesting that lesions previously designated as ALHE might represent a different pathologic entity.
